RBC Capital keeps a Buy rating and $82 price target on Cytokinetics (CYTK), saying the firm remains bullish on the stock following the ...

In a report released today, Manjari Dhar from RBC Capital maintained a Buy rating on Zalando (0QXN – Research Report), with a price target of ...

Fintel reports that on March 7, 2025, RBC Capital initiated coverage of Vertiv Holdings (NYSE:VRT) with a Outperform ...

Fintel reports that on March 7, 2025, RBC Capital initiated coverage of GH Research (NasdaqGM:GHRS) with a Outperform ...

Investing.com -- Galderma Group AG has been downgraded by RBC Capital Markets to "sector perform" from "outperform," ...

RBC Capital raised the firm’s price target on AdaptHealth (AHCO) to $14 from $11 and keeps an Outperform rating on the shares ...

Popular, Inc. (NASDAQ: BPOP) announced today that it will participate in the upcoming RBC Capital Markets Global Financial ...

RBC Capital Markets Global Financial Institutions Conference Transcript March 5, 2025 11:20 AM ETCompany ParticipantsJohn Stern ...

Canada's largest bank is bracing for the impact of a threatened U.S. 25% tariff on imports from north of the border. But the ...

RBC Capital Markets Financial Institutions Conference March 4, 2025 8:00 AM ETCompany ParticipantsDave McKay - ...

In the second quarter of last year, RBC closed its deal to takeover HSBC Bank Canada, which was Canada’s seventh-largest ...

Three of Canada's big five lenders - Royal Bank of Canada, TD Bank and CIBC - on Thursday beat analyst expectations for ...